ICD-10 Diagnosis Code C90.00

Multiple myeloma not having achieved remission

Diagnosis Code C90.00

ICD-10: C90.00
Short Description: Multiple myeloma not having achieved remission
Long Description: Multiple myeloma not having achieved remission
This is the 2017 version of the ICD-10-CM diagnosis code C90.00

Code Classification
  • Neoplasms
    • Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
      • Multiple myeloma and malignant plasma cell neoplasms (C90)

Information for Medical Professionals

Diagnostic Related Groups
The diagnosis code C90.00 is grouped in the following Diagnostic Related Group(s) (MS-DRG v33.0)


Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
  • 203.00 - Mult mye w/o achv rmson

  • Immunoglobulin A myeloma
  • Immunoglobulin D myeloma
  • Immunoglobulin G myeloma
  • Kappa light chain myeloma
  • Lambda light chain myeloma
  • Light chain myeloma
  • Multiple myeloma
  • Myeloma kidney
  • Myeloma-associated amyloidosis
  • Myeloma-associated primary systemic amyloidosis
  • Neuropathy associated with dysproteinemias
  • Neuropathy due to multiple myeloma
  • Non-secretory myeloma
  • Osteoporosis in multiple myelomatosis
  • Osteosclerotic myeloma
  • Paraneoplastic neuropathy
  • Paraneoplastic peripheral neuropathy
  • Primary systemic
  • Renal involvement in malignant disease
  • Systemic amyloidosis affecting skin

Index of Diseases and Injuries
References found for the code C90.00 in the Index of Diseases and Injuries:

Information for Patients

Multiple Myeloma

Also called: Plasma-cell myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.

No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include

  • Bone pain, often in the back or ribs
  • Broken bones
  • Weakness or fatigue
  • Weight loss
  • Frequent infections and fevers
  • Feeling very thirsty
  • Frequent urination

Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute

  • Bence-Jones protein - quantitative
  • Bone marrow transplant
  • Multiple myeloma
  • Protein electrophoresis - serum
  • Serum globulin electrophoresis
  • Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

Multiple myeloma Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. The bone marrow produces red blood cells, which carry oxygen throughout the body; white blood cells, which form the body's defenses (immune system); and platelets, which are necessary for blood clotting.Multiple myeloma is characterized by abnormalities in plasma cells, a type of white blood cell. These abnormal cells multiply out of control, increasing from about one percent of cells in the bone marrow to the majority of bone marrow cells. The abnormal cells form tumors within the bone, causing bone pain and an increased risk of fractures. If the tumors interfere with nerves near the bones, numbness or weakness in the arms or legs can occur. Affected individuals may also experience a loss of bone tissue, particularly in the skull, spine, ribs, and pelvis. The deterioration of bone can result in an excess of calcium in the blood (hypercalcemia), which can lead to nausea and loss of appetite, excessive thirst, fatigue, muscle weakness, and confusion.The abnormal plasma cells in multiple myeloma produce proteins that impair the development of normal blood cells. As a result, affected individuals may have a reduced number of red blood cells (anemia), which can cause fatigue, weakness, and unusually pale skin (pallor); a low number of white blood cells (leukopenia), which can result in a weakened immune system and frequent infections such as pneumonia; and a reduced number of platelets (thrombocytopenia), which can lead to abnormal bleeding and bruising. Kidney problems can also occur in this disorder, caused by hypercalcemia or by toxic proteins produced by the abnormal plasma cells.People with multiple myeloma typically develop the disorder around age 65. Over time, affected individuals can develop life-threatening complications, but the rate at which this happens varies widely. Some affected individuals are diagnosed incidentally when tests are done for other purposes and do not experience symptoms for years.
[Read More]
Previous Code
Previous Code C90.0
Next Code
C90.01 Next Code